Zydus Lifesciences Limited — Updates, 29-07-2025: Press Release

Zydus Lifesciences has completed the acquisition of an 85.6% stake in Amplitude Surgical for a total consideration of €25.6 Cr. This strategic move strengthens Zydus's presence in lower limb orthopaedics. The company will now launch a simplified tender offer for the remaining shares at €6.25 each. Zydus expects to secure over 90% ownership, followed by a squeeze-out to gain full control. Olivier Jallabert continues as CEO of Amplitude Surgical. This expansion signals Zydus's growth ambitions in global surgical technologies.